AI
PAHC icon

Axecap Investments’s Phibro Animal Health PAHC Stock Holding History

Axecap Investments’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-69,643
Closed -$3.85M – 86
2026
Q1 		$3.85M Sell
69,643
-15,305
-18% -$729K 2.65% 12
2025
Q4 		$3.17M Sell
84,948
-35,978
-30% -$1.46M 1.96% 20
2025
Q3 		$4.89M Sell
120,926
-58,507
-33% -$1.93M 3.02% 8
2025
Q2 		$4.58M Buy
179,433
+6,417
+4% +$140K 2.99% 11
2025
Q1 		$3.7M Buy
+173,016
New +$3.87M 3.13% 8

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Axecap Investments's PAHC Position: Q2 2026 in Review

Axecap Investments sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 69,643 shares — an estimated $3.85M sold.

Axecap Investments first reported a position in PAHC in Q1 2025 and held it in 5 quarters. The position peaked at $4.89M in Q3 2025. 209 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Axecap Investments reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Axecap Investments sold 69,643 Phibro Animal Health shares in Q2 2026, an estimated $3.85M.
  • Axecap Investments first reported a position in Phibro Animal Health in Q1 2025 and held it in 5 quarters.
  • Axecap Investments's Phibro Animal Health position peaked at $4.89M in Q3 2025.
  • 209 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Axecap Investments's 13F filing for Q2 2026, filed 10 Aug 2026.